Influenza vaccine uptake in adults aged 50-64 years: Policy and practice in England 2003/2004

被引:6
|
作者
Joseph, C
Elgohari, S
Nichols, T
Verlander, N
机构
[1] Hlth Protect Agcy Ctr Infect, Resp Dis Dept, London NW9 5EQ, England
[2] Hlth Protect Agcy Ctr Infect, State Modelling & Econ Dept, London NW9 5EQ, England
关键词
influenza; immunisation; vaccine uptake;
D O I
10.1016/j.vaccine.2005.10.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A small national study was carried out in England in 2003/2004 to ascertain the views of primary care trusts (PCTs) and general practitioners (GPs) on whether influenza immunisation should be extended to all people aged 50-64 years from the current recommendation of 65 years or more. Results showed that as many primary care trusts would be in favour, as would not be in favour. A similarly divided view was expressed by general practitioners. Vaccine uptake rates for high-risk (HR) and low-risk (LR) adults aged 50-64 years in the study population were higher in those practices where the GP was in favour of a more inclusive policy of offering flu vaccine to all persons aged 50 years or more, compared with those that did not favour this policy (60% versus 54% HR (p = 0.02) and 16% versus 11% LR (p = 0.02)). Higher rates of vaccine uptake for low-risk patients aged 50-64 years were also reported from practices where GPs perceived a greater health benefit of immunisation for this age group. Although policy for recommending vaccine to all patients aged 50 years or more is established elsewhere, opinion on whether such a policy should be adopted in England is currently divided amongst those providing local health services. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1786 / 1791
页数:6
相关论文
共 48 条
  • [1] Behavior and Beliefs About Influenza Vaccine Among Adults Aged 50-64 Years
    Santibanez, Tammy A.
    Mootrey, Gina T.
    Euler, Gary L.
    Janssen, Alan P.
    AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2010, 34 (01): : 77 - 89
  • [2] Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50-64 Years, and At-Risk Adults Aged 19-64 Years
    Choi, Min Joo
    Shin, Gyeongseon
    Kang, Daewon
    Lim, Jae-Ok
    Kim, Yun-Kyung
    Choi, Won Suk
    Yun, Jae-Won
    Noh, Ji Yun
    Song, Joon Young
    Kim, Woo Joo
    Choi, Sang-Eun
    Cheong, Hee Jin
    VACCINES, 2022, 10 (03)
  • [3] The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia
    Newall, Anthony T.
    Scuffham, Paul A.
    Kelly, Heath
    Harsley, Stuart
    MacIntyre, C. Raina
    VACCINE, 2008, 26 (17) : 2142 - 2153
  • [4] Burden of severe illness associated with laboratory confirmed influenza in adults aged 50-64 years: A rapid review
    Kim, Dong Kyu
    McGeer, Allison
    Uleryk, Elizabeth
    Coleman, Brenda L.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (04) : 632 - 642
  • [5] Modelling the influenza disease burden in people aged 50-64 and ≥65 years in Australia
    Moa, Aye M.
    Menzies, Robert, I
    Yin, J. Kevin
    MacIntyre, C. Raina
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (01) : 132 - 141
  • [6] Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50-64 Years of Age
    Poder, Airi
    Oberije, Janine
    Meyer, Jay
    Heymer, Peter
    Molrine, Deborah
    Versage, Eve
    Isakov, Leah
    Zhang, Qiuhong
    Hohenboken, Matthew
    VACCINES, 2023, 11 (10)
  • [7] Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years
    Jiménez, R
    Larrauri, A
    Carrasco, P
    Esteban, J
    Gómez-López, LI
    Gil, A
    VACCINE, 2003, 21 (25-26) : 3550 - 3555
  • [8] Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea
    Jang, Hyeongap
    Kim, Joon Hyung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 959 - 966
  • [9] Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old
    Raj, Suresh Mahendra
    Chughtai, Abrar Ahmad
    Sharma, Anurag
    Tan, Timothy C.
    Maclntyre, C. Raina
    VACCINE, 2019, 37 (40) : 5979 - 5985
  • [10] Influenza vaccine uptake among at-risk adults (aged 16–64 years) in the UK: a retrospective database analysis
    Simon Oakley
    Julien Bouchet
    Paul Costello
    James Parker
    BMC Public Health, 21